A Study to Determine the Safety of AV-1, an Antibody Being Developed for Treatment of Dengue, in Healthy Volunteers
Clinical trial NCT04273217 · COMPLETED
Trial details
- NCT number
- NCT04273217
- Sponsor
- AbViro LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-04
- Primary completion
- 2021-07-08
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.